
Read More
Why Nifty Pharma Fell Today: Trump's Generic Drug Tariff Plan Sparks Sellin...
President Trump announced that imported generic medicines will continue to attract a 0 per cent tari...

President Trump announced that imported generic medicines will continue to attract a 0 per cent tari...

Orchid Pharma entered into a licensing and supply agreement with Russia's Pharmasyntez JSC to commer...

India's pharma services industry is riding a global supply chain shift away from China. Here's how t...

The BSE Sensex climbed as much as 0.90 per cent (752.26 points) to an intraday high of 84,134.97 bef...

At the closing bell, the Nifty 50 declined by 156.10 points or 0.63 per cent to end at 24,680.90, wh...

Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market...

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing F...

FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!...

A leading player in personal protection and healthcare products expands its international footprint...

FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance...